Ascentage Pharma Group International ASPHF
$4.53
Last Updated: Jul 14, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
ASPHF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Ascentage Pharma Group International is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Ascentage Pharma Group International. Stock Analysis ASPHF
United States Health Care Small Cap Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 767 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Ascentage Pharma Group International (ASPHF) Chart
Financial Metrics & Statements of Ascentage Pharma Group International (ASPHF)
FAQ's for Ascentage Pharma Group International (ASPHF)
- As of August 2026, Ascentage Pharma Group International ASPHF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ascentage Pharma Group International using these criteria to determine its compliance status.
- Muslim investors may consider investing in Ascentage Pharma Group International if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Ascentage Pharma Group International by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Ascentage Pharma Group International may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Ascentage Pharma Group International on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Ascentage Pharma Group International (ASPHF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
